The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F COVER PAGE

OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8

Report for the Calendar Year or Quarter Ended: 06-30-2022
Check here if Amendment   Amendment Number:
This Amendment (Check only one.):   is a restatement.
  adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Birchview Capital, LP
Address: 688 PINE STREET, SUITE D
C/O BIRCHVIEW CAPITAL
BURLINGTON , VT05401
Form 13F File Number: 028-16416

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

Person Signing this Report on Behalf of Reporting Manager:
Name: Richard McCormick
Title: CFO
Phone: (802) 923-3826
Signature, Place, and Date of Signing:
Richard McCormick Burlington , VT 06-30-2022
[Signature] [City, State] [Date]
Report Type (Check only one.):
X 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)
  13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)
  13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)
Form 13F Summary Page
Report Summary:
Number of Other Included Managers: 0
Form 13F Information Table Entry Total: 64
Form 13F Information Table Value Total: 137,477
(thousands)
List of Other Managers Reporting for this Manager:
[If there are no entries in this list, omit this section.]
Form 13F File Number Name

List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.
[If there are no entries in this list, state “NONE” and omit the column headings and list entries.]
No. Form 13F File Number Name


SEC FORM 13F-HR

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
2SEVENTY BIO INC COM 901384107 790 59,833 SH SOLE 59,833 0 0
ACADIA PHARMACEUTICALS INC COM 004225108 3,514 249,400 SH SOLE 249,400 0 0
ACCELERATE DIAGNOSTICS INC COM 00430H102 2,236 2,252,388 SH SOLE 2,252,388 0 0
AKEBIA THERAPEUTICS INC COM 00972D105 0 0 SH SOLE 0 0 0
ALBIREO PHARMA INC COM 01345P106 2,244 113,000 SH SOLE 113,000 0 0
ALKERMES PLC SHS G01767105 1,490 50,000 SH SOLE 50,000 0 0
AMARIN CORP PLC SPONS ADR NEW 023111206 0 0 SH SOLE 0 0 0
AMICUS THERAPEUTICS INC COM 03152W109 408 38,000 SH SOLE 38,000 0 0
ANGION BIOMEDICA CORP COM 03476J107 62 54,392 SH SOLE 54,392 0 0
APELLIS PHARMACEUTICALS INC COM 03753U106 543 12,000 SH SOLE 12,000 0 0
ARVINAS INC COM 04335A105 631 15,000 SH SOLE 15,000 0 0
ASPIRA WOMEN'S HEALTH INC COM 04537Y109 49 83,104 SH SOLE 83,104 0 0
AVEO PHARMACEUTICALS INC COM 053588307 918 140,000 SH SOLE 140,000 0 0
AZIYO BIOLOGICS INC COM 05479K106 10,026 1,418,123 SH SOLE 1,418,123 0 0
BIOCRYST PHARMACEUTICALS INC COM 09058V103 212 20,000 SH SOLE 20,000 0 0
BIODESIX INC COM 09075X108 2,929 1,811,412 SH SOLE 1,811,412 0 0
BIOGEN INC COM 09062X103 0 0 SH SOLE 0 0 0
BIOHAVEN PHARMACEUTICAL HOLDING CO LTD COM G11196105 2,186 15,000 SH SOLE 15,000 0 0
BLUEBIRD BIO INC COM 09609G100 406 98,000 SH SOLE 98,000 0 0
BRISTOL-MYERS SQUIBB CO COM 110122108 56,039 727,785 SH SOLE 727,785 0 0
CHEMOCENTRYX INC COM 16383L106 496 20,000 SH SOLE 20,000 0 0
CONCERT PHARMACEUTICALS INC COM 206022105 84 20,000 SH SOLE 20,000 0 0
CONTINENTAL RESOURCES INC COM 212015101 2,523 38,600 SH SOLE 38,600 0 0
CONTRAFECT CORP COM 212326102 614 200,000 SH SOLE 200,000 0 0
CORCEPT THERAPEUTICS INC COM 218352102 1,189 50,000 SH SOLE 50,000 0 0
CULLINAN MANAGEMENT INC COM 230031106 578 45,114 SH SOLE 45,114 0 0
CYTOKINETICS INC COM 23282W605 982 25,000 SH SOLE 25,000 0 0
DOCGO INC COM 256086109 785 110,000 SH SOLE 110,000 0 0
EQUITRANS MIDSTREAM CORPORATIO COM 294600101 846 133,050 SH SOLE 133,050 0 0
FOGHORN THERAPEUTICS INC COM 344174107 3,874 284,843 SH SOLE 284,843 0 0
G1 THERAPEUTICS INC COM 3621LQ109 198 40,000 SH SOLE 40,000 0 0
GOSSAMER BIO INC COM 38341P102 1,332 159,088 SH SOLE 159,088 0 0
HARROW HEALTH INC COM 415858109 1,310 180,000 SH SOLE 180,000 0 0
IMMUNOGEN INC COM 45253H101 675 150,000 SH SOLE 150,000 0 0
INARI MEDICAL INC COM 45332Y109 680 10,000 SH SOLE 10,000 0 0
INFLARX NV COM N44821101 102 70,000 SH SOLE 70,000 0 0
INHIBRX INC COM 45720L107 800 70,448 SH SOLE 70,448 0 0
IRHYTHM TECHNOLOGIES INC COM 450056106 432 4,000 SH SOLE 4,000 0 0
IVERIC BIO INC COM 46583P102 144 15,000 SH SOLE 15,000 0 0
KALVISTA PHARMACEUTICALS INC COM 483497103 394 40,000 SH SOLE 40,000 0 0
KARYOPHARM THERAPEUTICS INC COM 48576U106 1,215 269,332 SH SOLE 269,332 0 0
KINIKSA PHARMACEUTICALS LTD COM G5269C101 291 30,000 SH SOLE 30,000 0 0
LAIRD SUPERFOOD INC COM 50736T102 53 28,000 SH SOLE 28,000 0 0
MASIMO CORP COM 574795100 1,997 15,280 SH SOLE 15,280 0 0
NEKTAR THERAPEUTICS COM 640268108 486 128,000 SH SOLE 128,000 0 0
NEUROCRINE BIOSCIENCES INC COM 64125C109 8,309 85,240 SH SOLE 85,240 0 0
OVINTIV INC COM 69047Q102 3,721 84,200 SH SOLE 84,200 0 0
PHREESIA INC COM 71944F106 2,068 82,700 SH SOLE 82,700 0 0
PIONEER NATURAL RESOURCES CO COM 723787107 848 3,800 SH SOLE 3,800 0 0
PROTAGONIST THERAPEUTICS INC COM 74366E102 301 38,000 SH SOLE 38,000 0 0
PROTHENA CORP PLC SHS G72800108 2,784 102,548 SH SOLE 102,548 0 0
QUIDELORTHO CORP COM 74838J101 5,958 61,306 SH SOLE 61,306 0 0
SIENTRA INC COM 82621J105 34 40,000 SH SOLE 40,000 0 0
SILK ROAD MEDICAL INC COM 82710M100 364 10,000 SH SOLE 10,000 0 0
SOLENO THERAPEUTICS INC COM 834203101 680 3,676,899 SH SOLE 3,676,899 0 0
STOKE THERAPEUTICS INC COM 86150R107 198 15,000 SH SOLE 15,000 0 0
TURNING POINT THERAPEUTICS INC COM 90041T108 602 8,000 SH SOLE 8,000 0 0
UNITED THERAPEUTICS CORP COM 91307C102 3,535 15,000 SH SOLE 15,000 0 0
VANDA PHARMACEUTICALS INC COM 921659108 0 0 SH SOLE 0 0 0
VENTYX BIOSCIENCES INC COM 92332V107 404 33,000 SH SOLE 33,000 0 0
XENCOR INC COM 98401F105 337 12,300 SH SOLE 12,300 0 0
XENON PHARMACEUTICALS INC COM 98420N105 304 10,000 SH SOLE 10,000 0 0
YIELD10 BIOSCIENCE INC COM 98585K102 42 18,750 SH SOLE 18,750 0 0
ZENTALIS PHARMACEUTICALS INC COM 98943L107 225 8,000 SH SOLE 8,000 0 0